Summary
Introduction
This brief provides five key predictions for the trends shaping the pharmaceutical market in 2007 and beyond, and explains the impact of these predictions on the industry. Predictions discussed include the continued influence of M&A and licensing, the increasing impact of cost containment policies by payers and an increasing reliance on biologics to drive growth.
Scope
- An overview of the drivers and impact of increasing generic penetration in the major pharmaceutical markets
- A summary of our analysis of Big Pharma's increasing reliance on biologic therapies to drive growth
- A review of the expected impact of Medicare Part D on the US pharmaceutical market over the next few years
Highlights
Within the next five years an estimated $80 billion in 2005 product sales will be exposed to generic competition. The focus of payers on encouraging generic penetration will increase the impact of these patent expiries on branded pharma, and generate a favorable environment for generics companies to drive growth
As patent expiries increasingly impact small molecule blockbusters the pharmaceutical industry is focusing more heavily on biotechnology to drive future growth
Reasons to Purchase
- Understand the key trends shaping the pharmaceutical market over the coming years
- Gain insight into our predictions for the future impact of key trends
|
